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A B S T R A C T
A study was performed to determine the impact
of drug resistance in tuberculosis among immi-
grant patients in Madrid, Spain. During the
period 1995–2001, the relative proportion of iso-
lates from immigrant patients increased from
4.4% to 24.2%. No differences between immi-
grants and Spanish-born patients were detected
for resistance to any first-line anti-tuberculous
drug. More studies are required to determine the
actual incidence of resistant tuberculosis in immi-
grants.
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The importance of globalisation and mass move-
ments of populations in the epidemiology of
tuberculosis is a fact that has been recognised
previously in many studies [1,2]. One particular
aspect that has been a subject of concern is the risk
of spread of resistant strains among the population
[3]. Recent reports suggest different prophylactic
regimens for patients according to their country of
origin [4]. Spain is of special interest because it is
between the European Union and Northern Africa,
and is also the destination of many immigrants
from Central and South America. This Research
Note compares resistance data for immigrants in
Madrid with data for Spanish-born people in the
period 1995–2001.
During the study period, 457 consecutive
patients were diagnosed with tuberculosis by
culture. Among these, 69 were immigrants from
different geographical areas (Ecuador and Mor-
occo, 16 cases each; Peru, six cases; Colombia, five
cases; Portugal, four cases; and other countries
from South America, Africa and Asia, all with less
than three cases each). The relative percentage of
isolates from immigrants with tuberculosis grew
from 4.4% in 1995 to 24.2% in 2001 (p < 0.01,
v2 for trends).
All samples in the study period were processed
according to commonly accepted protocols, and
all the isolates were sent to the Centro Nacional
de Microbiologı´a (Majadahonda, Spain) to con-
firm the identification and susceptibility testing
results. The isolates were identified as Mycobacte-
rium tuberculosis in 440 cases, M. bovis in 13 cases,
and M. africanum in four cases. All M. bovis
isolates were from Spanish-born patients, and all
M. africanum isolates were from immigrant
patients.
Resistance to at least one of the first-line
anti-tuberculous drugs was detected in four
(5.8%) isolates among immigrants, and in
28 (6.7%) isolates among Spanish-born patients.
These data could be influenced by the isolation
of several multidrug-resistant M. bovis strains
from unrelated patients that were related tem-
porally to strains from several outbreaks repor-
ted previously. When only M. tuberculosis
isolates from immigrant and Spanish-born
patients were compared for drug resistance, no
statistically significant differences were detected
for any of the antimicrobial agents included in
the study (Fisher’s exact test; Table 1), although
a slight increase in the resistance rates among
immigrant patients was observed. Only two
immigrants (both from South America) showed
multidrug-resistant tuberculosis, and in both
cases the resistance was secondary to inadequate
therapies. No resistant strains were isolated from
African patients.
The importance of migration in the epidemi-
ology of tuberculosis in developed countries has
recently been of increasing interest [5–8]. In
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several reports, tuberculosis in this population
represented a significant proportion of the total
cases recognised, and even the majority of cases
in some countries [8,9]. The knowledge that
resistance rates in some of the origin countries
are higher than in the destination countries
[3,10,11], and that the risk of transmission exists,
albeit at a low frequency, between immigrants
and local populations [12], highlights the risk of
introduction of drug-resistant strains into coun-
tries which currently have a low incidence of
such strains. In many studies, immigrant pa-
tients had higher rates of resistance than native
patients [7,13–15], but contrasting data have
been obtained in other studies [16]. According
to the data in the present study, tuberculosis in
immigrants in Madrid shows similar resistance
rates to those found in Spanish-born patients,
and even multidrug-resistant strains were not
the result of primary resistance, but secondary to
inadequate therapy. Perhaps differences in the
immigrant populations could explain the differ-
ences between the various studies. The relatively
low number of cases in the present study is an
important limitation, especially when other stud-
ies in Spain have yielded different results [6,14].
A large study is needed to establish the actual
resistance rates in native and immigrant popu-
lations. Until such data are available, treatment
with four drugs, coupled with a proper history
of previous therapies and the perfomance of
cultures and antibiograms, must be regarded as
necessary practice for the management of immi-
grant patients.
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Table 1. Resistance rates of Mycobacterium tuberculosis
among immigrants and Spanish-born patients
Antibiotic
Spanish-born
(n = 406)
% resistance (n)
Immigrants
(n = 65)
% resistance (n) p
Isoniazid 3.0% (12) 4.7% (3) 0.471
Rifampicin 1.5% (6) 3.1% (2) 0.333
Streptomycin 1.2% (5) 3.1% (2) 0.274
Ethambutol 0.5% (2) 1.6% (1) 0.380
Pyrazinamide 0.5% (2) 3.1% (2) 0.117
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